J&J;, Isis to partner on diabetes drug
From Times Wire Reports
Johnson & Johnson will pay Isis Pharmaceuticals Inc. about $275 million to develop two drugs for diabetes, Isis said.
Carlsbad-based Isis will initially receive $45 million, and may be paid $230 million or more for meeting milestones for the as-yet unnamed medicines.
